Senior insider sale
PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$13.24M
201.92K shares
What this filing means
TORLEY HELEN plans to sell 201.92K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $13.24M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001968582-26-000422
DirectorOfficer· PRESIDENT AND CEO
Since Mar 2026
201.92K
Shares to sell
$13.24M
Approx. market value
101.92K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
5/11/2026
101.92KTotal acquired101.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/11/2026 | Stock Option Exercise Cash | 101.92K | — |
| Total | 101.92K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
10K
Market value
$635.0K
4/6/2026
—Completed
Units to sell
20K
Market value
$1.28M
4/2/2026
—Completed
Units to sell
20K
Market value
$1.31M
4/1/2026
—Completed
Units to sell
10K
Market value
$702.1K
3/4/2026
—Completed
Units to sell
20K
Market value
$1.38M
3/3/2026
—Completed
Units to sell
20K
Market value
$1.39M
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
101.92K
Market value
$6.54M
5/11/2026
Total
Units
201.92K
Value
$13.24M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/6/2026 | 10K | $635.0K | — | Completed |
4/2/2026 | 20K | $1.28M | — | Completed |
4/1/2026 | 20K | $1.31M | — | Completed |
3/4/2026 | 10K | $702.1K | — | Completed |
3/3/2026 | 20K | $1.38M | — | Completed |
3/2/2026 | 20K | $1.39M | — | Completed |
| Planned — Approximate Date | ||||
5/11/2026 | 101.92K | $6.54M | NASDAQ | Planned |
| Total | 201.92K | $13.24M | ||